Properties (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:affiliatedWith |
gptkb:ABC_Research_Lab
|
| gptkbp:built |
formulation stability
|
| gptkbp:campusFacilities |
gptkb:XYZ_University
|
| gptkbp:chemicalFormula |
white crystalline solid
reacts with amines contains a pyrimidine ring pyrimidine derivative C12H15N3O2 |
| gptkbp:clinicalTrials |
Phase II
targeted therapy |
| gptkbp:collaborations |
pharmaceutical companies
international partnerships |
| gptkbp:community_service |
progression-free survival
|
| gptkbp:compatibleWith |
inhibitor of cell proliferation
anti-tumor |
| gptkbp:competitors |
high
similar compounds |
| gptkbp:composedOf |
high yield
multi-step organic synthesis |
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:drugInterdiction |
granted
|
| gptkbp:environmentalImpact |
low toxicity
|
| gptkbp:financial_aid |
stable at room temperature
|
| gptkbp:formulation |
tablet
|
| gptkbp:funding |
government grant
|
| gptkbp:future_plans |
combination therapies
investigational |
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-1276
|
| gptkbp:impact |
nausea
|
| gptkbp:is_aimed_at |
cancer
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:judgingCriteria |
HPLC
|
| gptkbp:market |
not yet marketed
|
| gptkbp:notableWork |
significant
|
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)-6-methylpyrimidin-2-yl)benzamide
|
| gptkbp:patentAssignee |
gptkb:XYZ_Pharmaceuticals
|
| gptkbp:patentNumber |
US1234567
|
| gptkbp:patentStatus |
patented
|
| gptkbp:publications |
multiple peer-reviewed articles
|
| gptkbp:regulatoryCompliance |
under review
|
| gptkbp:releaseYear |
2010
|
| gptkbp:research_focus |
oncology
preclinical |
| gptkbp:researchAndDevelopment |
promising results.
|
| gptkbp:route |
oral
|
| gptkbp:safety_features |
under evaluation
|
| gptkbp:safetyFeatures |
ongoing
|
| gptkbp:storage |
cool and dry place
|
| gptkbp:targets |
specific protein kinase
|
| gptkbp:triggerType |
inhibition of kinase activity
|
| gptkbp:uses |
research in pharmacology
|
| gptkbp:weight |
233.27 g/mol
|